Patent · US Active

Method for treating, managing, inhibiting, or preventing obesity

US9877946B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 9, 2016
Grant dateJan 30, 2018
Priority date
Expiry dateDec 9, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/1384
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition for inducing differentiation into beige adipocytes from white adipocytes, including butein, a butein derivative, or a pharmaceutically available salt thereof as an active ingredient, and a method of inducing the differentiation are provided. Increases in expressions of UCP-1 and PRDM4 are confirmed using the active ingredient, that is, the butein or butein derivative, and therefore the composition is expected to be used in preventing or treating obesity, and more basically, for target treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.